Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX

doi:10.1016/j.taap.2006.11.002

Title: Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX

Full Record
Similar

Abstract

To develop therapeutics against lung injury and respiratory toxicity following nerve agent VX exposure, we evaluated the protective efficacy of a number of potential pulmonary therapeutics. Guinea pigs were exposed to 27.03 mg/m{sup 3} of VX or saline using a microinstillation inhalation exposure technique for 4 min and then the toxicity was assessed. Exposure to this dose of VX resulted in a 24-h survival rate of 52%. There was a significant increase in bronchoalveolar lavage (BAL) protein, total cell number, and cell death. Surprisingly, direct pulmonary treatment with surfactant, liquivent, N-acetylcysteine, dexamethasone, or anti-sense syk oligonucleotides 2 min post-exposure did not significantly increase the survival rate of VX-exposed guinea pigs. Further blocking the nostrils, airway, and bronchioles, VX-induced viscous mucous secretions were exacerbated by these aerosolized treatments. To overcome these events, we developed a strategy to protect the animals by treatment with atropine. Atropine inhibits muscarinic stimulation and markedly reduces the copious airway secretion following nerve agent exposure. Indeed, post-exposure treatment with atropine methyl bromide, which does not cross the blood-brain barrier, resulted in 100% survival of VX-exposed animals. Bronchoalveolar lavage from VX-exposed and atropine-treated animals exhibited lower protein levels, cell number, and cell death compared to VX-exposed controls, indicatingmore »« less

Authors:

Nambiar, Madhusoodana P. ^[1]; Gordon, Richard K. ^[2]; Rezk, Peter E. ^[2]; Katos, Alexander M. ^[2]; Wajda, Nikolai A. ^[2]; Moran, Theodore S. ^[3]; Steele, Keith E. ^[4]; Doctor, Bhupendra P. ^[2]; Sciuto, Alfred M. ^[3]

Department of Biochemical Pharmacology/Division of Biochemistry, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910-7500 (United States) and Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814 (United States). E-mail: Madhusoodana.nambiar@na.amedd.army.mil
Department of Biochemical Pharmacology/Division of Biochemistry, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910-7500 (United States)
Medical Toxicology Branch /Analytical Toxicology Division, United States Army Medical Research Institute of Chemical Defense, 3100 Ricketts Point Road, Edgewood, MD 21010-5400 (United States)
Department of Pathology, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910-7500 (United States)

Publication Date:: Thu Mar 15 00:00:00 EDT 2007

OSTI Identifier:: 20976879

Resource Type:: Journal Article

Resource Relation:: Journal Name: Toxicology and Applied Pharmacology; Journal Volume: 219; Journal Issue: 2-3; Other Information: DOI: 10.1016/j.taap.2006.11.002; PII: S0041-008X(06)00413-3; Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA)

Country of Publication:: United States

Language:: English

Subject:: 60 APPLIED LIFE SCIENCES; APOPTOSIS; ATROPINE; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CHEMICAL WARFARE; DEXAMETHASONE; ESTERS; FLUIDS; GUINEA PIGS; INHALATION; INJURIES; LAVAGE; LUNGS; METHYL BROMIDE; OLIGONUCLEOTIDES; PROTEINS; SECRETION; TOXICITY

Citation Formats


                    Nambiar, Madhusoodana P., Gordon, Richard K., Rezk, Peter E., Katos, Alexander M., Wajda, Nikolai A., Moran, Theodore S., Steele, Keith E., Doctor, Bhupendra P., and Sciuto, Alfred M.. Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX.  United States: N. p., 2007. 
        Web.  doi:10.1016/j.taap.2006.11.002.

Copy to clipboard


                    Nambiar, Madhusoodana P., Gordon, Richard K., Rezk, Peter E., Katos, Alexander M., Wajda, Nikolai A., Moran, Theodore S., Steele, Keith E., Doctor, Bhupendra P., & Sciuto, Alfred M.. Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX.  United States.  doi:10.1016/j.taap.2006.11.002.

Copy to clipboard


                    Nambiar, Madhusoodana P., Gordon, Richard K., Rezk, Peter E., Katos, Alexander M., Wajda, Nikolai A., Moran, Theodore S., Steele, Keith E., Doctor, Bhupendra P., and Sciuto, Alfred M.. Thu .  
        "Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX".  United States.  
        doi:10.1016/j.taap.2006.11.002.

Copy to clipboard


                    
@article{osti_20976879,

  title        = {Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX},

  author       = {Nambiar, Madhusoodana P. and Gordon, Richard K. and Rezk, Peter E. and Katos, Alexander M. and Wajda, Nikolai A. and Moran, Theodore S. and Steele, Keith E. and Doctor, Bhupendra P. and Sciuto, Alfred M.},

  abstractNote = {To develop therapeutics against lung injury and respiratory toxicity following nerve agent VX exposure, we evaluated the protective efficacy of a number of potential pulmonary therapeutics. Guinea pigs were exposed to 27.03 mg/m{sup 3} of VX or saline using a microinstillation inhalation exposure technique for 4 min and then the toxicity was assessed. Exposure to this dose of VX resulted in a 24-h survival rate of 52%. There was a significant increase in bronchoalveolar lavage (BAL) protein, total cell number, and cell death. Surprisingly, direct pulmonary treatment with surfactant, liquivent, N-acetylcysteine, dexamethasone, or anti-sense syk oligonucleotides 2 min post-exposure did not significantly increase the survival rate of VX-exposed guinea pigs. Further blocking the nostrils, airway, and bronchioles, VX-induced viscous mucous secretions were exacerbated by these aerosolized treatments. To overcome these events, we developed a strategy to protect the animals by treatment with atropine. Atropine inhibits muscarinic stimulation and markedly reduces the copious airway secretion following nerve agent exposure. Indeed, post-exposure treatment with atropine methyl bromide, which does not cross the blood-brain barrier, resulted in 100% survival of VX-exposed animals. Bronchoalveolar lavage from VX-exposed and atropine-treated animals exhibited lower protein levels, cell number, and cell death compared to VX-exposed controls, indicating less lung injury. When pulmonary therapeutics were combined with atropine, significant protection to VX-exposure was observed. These results indicate that combinations of pulmonary therapeutics with atropine or drugs that inhibit mucous secretion are important for the treatment of respiratory toxicity and lung injury following VX exposure.},

  doi          = {10.1016/j.taap.2006.11.002},

  journal      = {Toxicology and Applied Pharmacology},

  number       = 2-3,

  volume       = 219,

  place        = {United States},

  year         = {Thu Mar 15 00:00:00 EDT 2007},

  month        = {Thu Mar 15 00:00:00 EDT 2007}

}

Copy to clipboard

Journal Article:

DOI: 10.1016/j.taap.2006.11.002

Other availability

Find in Google Scholar

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Acute respiratory toxicity following inhalation exposure to soman in guinea pigs

Perkins, Michael W. ; Pierre, Zdenka ; Rezk, Peter ; ... - Toxicology and Applied Pharmacology

Respiratory toxicity and lung injury following inhalation exposure to chemical warfare nerve agent soman was examined in guinea pigs without therapeutics to improve survival. A microinstillation inhalation exposure technique that aerosolizes the agent in the trachea was used to administer soman to anesthetized age and weight matched male guinea pigs. Animals were exposed to 280, 561, 841, and 1121 mg/m{sup 3} concentrations of soman for 4 min. Survival data showed that all saline controls and animals exposed to 280 and 561 mg/m{sup 3} soman survived, while animals exposed to 841, and 1121 mg/m{sup 3} resulted in 38% and 13% survival,more »« less
DOI: 10.1016/j.taap.2010.02.016
Development and Application of Acute Exposure Guideline Levels (AEGLs) for Chemical Warfare Nerve and Sulfur Mustard Agents.

Watson, Annetta Paule ; Opresko, Dennis M ; Young, Robert A ; ... - Journal of Toxicology and Environmental Health Part B: Critical Reviews

Acute exposure guideline levels (AEGLs) have been developed for the chemical warfare agents GB, GA, GD, GF, VX, and sulfur mustard. These AEGLs were approved by the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances after Federal Register publication and comment, and judged as scientifically valid by the National Research Council Committee on Toxicology Subcommittee on AEGLs. AEGLs represent general public exposure limits for durations ranging from 10 min to 8 h, and for three levels of severity (AEGL-1, AEGL-2, AEGL-3). Mild effects are possible at concentrations greater than AEGL-1, while life-threatening effects are expected at concentrationsmore »« less
DOI: 10.1080/15287390500194441
Subchronic exposure to low-doses of the nerve agent VX: Physiological, behavioral, histopathological and neurochemical studies

Bloch-Shilderman, Eugenia ; Rabinovitz, Ishai ; Egoz, Inbal ; ... - Toxicology and Applied Pharmacology

The highly toxic organophosphorous compound VX [O-ethyl-S-(isoporopylaminoethyl) methyl phosphonothiolate] undergoes an incomplete decontamination by conventional chemicals and thus evaporates from urban surfaces, e.g., pavement, long after the initial insult. As a consequence to these characteristics of VX, even the expected low levels should be examined for their potential to induce functional impairments including those associated with neuronal changes. In the present study, we developed an animal model for subchronic, low-dose VX exposure and evaluated its effects in rats. Animals were exposed to VX (2.25 {mu}g/kg/day, 0.05 LD{sub 50}) for three months via implanted mini osmotic pumps. The rapidly attained continuousmore »« less
DOI: 10.1016/j.taap.2008.03.024
Development and assessment of countermeasure formulations for treatment of lung injury induced by chlorine inhalation

Hoyle, Gary W., E-mail: Gary.Hoyle@louisville.edu ; Chen, Jing ; Schlueter, Connie F. ; ... - Toxicology and Applied Pharmacology

Chlorine is a commonly used, reactive compound to which humans can be exposed via accidental or intentional release resulting in acute lung injury. Formulations of rolipram (a phosphodiesterase inhibitor), triptolide (a natural plant product with anti-inflammatory properties), and budesonide (a corticosteroid), either neat or in conjunction with poly(lactic:glycolic acid) (PLGA), were developed for treatment of chlorine-induced acute lung injury by intramuscular injection. Formulations were produced by spray-drying, which generated generally spherical microparticles that were suitable for intramuscular injection. Multiple parameters were varied to produce formulations with a wide range of in vitro release kinetics. Testing of selected formulations in chlorine-exposedmore »« less
DOI: 10.1016/J.TAAP.2016.03.001
EVALUATION OF LUNG BURDEN FOLLOWING ACUTE INHALATION EXPOSURE TO HIGHLY INSOLUBLE PuO .

Mann, J.R. ; Kirchner, R.A. - Health Phys., 13: 877-82 (Aug. 1967).
DOI: 10.1097/00004032-196708000-00007